| [1] |
Lakhoo J, Bui JT, Zivin SP, et al. Root cause analysis of rebleeding events following transjugular intrahepatic portosystemic shunt creation for variceal hemorrhage[J]. J Vasc Interv Radiol, 2015, 26(10):1444-1453.
|
| [2] |
Berry K, Lerrigo R, Liou IW, et al. Association between transjugular intrahepatic portosystemic shunt and survival in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2016, 14(1):118-123.
|
| [3] |
Luca A, Miraglia R, Maruzzelli L, et al. Early liver failure after transjugular intrahepatic portosystemic shunt in patients with cirrhosis with model for end-stage liver disease score of 12 or less: incidence, outcome, and prognostic factors[J]. Radiology, 2016, 280(2):622-629.
|
| [4] |
Ahmed R, Santhanam P, Rayyan Y. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt[J]. Eur J Gastroenterol Hepatol, 2015, 27(10):1226-1227.
|
| [5] |
Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension:update 2009[J]. Hepatology, 2010, 51(1):306.
|
| [6] |
Wu X, Ding W, Cao J, et al. Functional hepatic flow can predict the hepatic reserve function in surgical cirrhotic patients[J]. J Invest Surg, 2009, 22(3):178-182.
|
| [7] |
Ascha M, Abuqayyas S, Hanouneh I, et al. Predictors of mortality after transjugular portosystemic shunt[J]. World J Hepatol, 2016, 8(11):520-529.
|
| [8] |
Angeloni S, Merli M, Salvatori FM, et al. Polytetrafluoroethylene-covered stent grafts for TIPS procedure:1-year patency and clinical results[J]. Am J Gastroenterol, 2004, 99(2):280-285.
|
| [9] |
Wu X, Ding W, Cao J, et al. Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension[J]. Am Surg, 2013, 79(3):305-312.
|
| [10] |
Ferral H, Gomez-Reyes E, Fimmel CJ. Post-transjugular intrahepatic portosystemic shunt follow-up and management in the VIATORR Era[J]. Tech Vasc Interv Radiol, 2016, 19(1):82-88.
|
| [11] |
Shah RP, Sze DY. Complications during transjugular intrahepatic portosystemic shunt creation[J]. Tech Vasc Interv Radiol, 2016, 19(1):61-73.
|
| [12] |
Bureau C, Garcia Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts:long-term results of a randomized multicentre study[J]. Liver Int, 2007, 27(6):742-747.
|
| [13] |
胡朋，陈斯良，罗泽龙，等．采用裸支架联合覆膜支架建立经颈静脉肝内门体分流术的中远期疗效[J]. 中国介入影像与治疗学，2016,13(7):394-397.
|
| [14] |
吴性江，曹建民，韩建明，等．覆膜支架和裸支架行TIPS治疗门静脉高压症的对比研究[J]．中华外科杂志，2010,48(2):83-87.
|
| [15] |
Angermayr B, Cejna M, Koenig F, et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt:ePTFE-covered stentgrafts versus bare stents[J]. Hepatology, 2003, 38(4):1043-1050.
|
| [16] |
Ruiz-Blard E, Baiges A, Turon F, et al. Early transjugular intrahepatic portosystemic shunt:when, how and in whom?[J]. Gastroenterol Hepatol, 2016, 39(7):472-476.
|
| [17] |
Bai M, He CY, Qi XS, et al. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt[J]. World J Gastroenterol, 2014, 20(3):774-785.
|
| [18] |
梁松年，徐克．TIPS中8 mm直径覆膜支架应用的临床研究[J]. 介入放射学杂志，2008,17(2):98-101.
|
| [19] |
Gaba RC. Transjugular intrahepatic portosystemic shunt creation with embolization or obliteration for variceal bleeding[J]. Tech Vasc Interv Radiol, 2016, 19(1):21-35.
|
| [20] |
Tesdal IK, Filser T, Weiss C, et al. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding[J]. Radiology, 2005, 236(1):360-367.
|